<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04871581</url>
  </required_header>
  <id_info>
    <org_study_id>NTI v Placebo</org_study_id>
    <nct_id>NCT04871581</nct_id>
  </id_info>
  <brief_title>Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device</brief_title>
  <official_title>Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device: Overview and Results of a Placebo-Controlled Crossover Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ChairsideSplint.com</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ChairsideSplint.com</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single blinding study comparing FDA cleared device for prevention of medically diagnosed&#xD;
      migraine pain to placebo.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to determine if nocturnal jaw clenching can be an influence on chronic migraine&#xD;
      pain, the FDA cleared &quot;NTI&quot; (Nociceptive Trigeminal Inhibition) device with the Indications&#xD;
      for Use of &quot;for prophylactic treatment of medically diagnosed migraine pain&quot; was compared to&#xD;
      a similar device that had no influence on jaw clenching.The HIT-6 (Headache Impact Test)&#xD;
      score was selected as the outcome measure, as the goal was to focus on improving disability&#xD;
      in sufferer's lives, as in chronic migraine, changes in headache days may not be as helpful&#xD;
      as improving disability.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Single blinded cross-over study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants were advised that two different designs of device were being compared to each other.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of negative impact on life</measure>
    <time_frame>one month</time_frame>
    <description>At least a one-category improvement in subject's HIT-6 score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Chronic Migraine, Headache</condition>
  <arm_group>
    <arm_group_label>Device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects receiving the FDA-cleared device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects receiving the sham device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NTI-tss</intervention_name>
    <description>FDA cleared device for prophylactic treatment of medically diagnosed migraine pain</description>
    <arm_group_label>Device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Similar to Device, but having no influence on clenching intensity</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Diagnosed with chronic migraine at a neurology clinic -&#xD;
&#xD;
        Exclusion Criteria: none&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Boyd James</name>
      <address>
        <city>Solana Beach</city>
        <state>California</state>
        <zip>92075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol. 2000 Jun;13(3):277-83. Review.</citation>
    <PMID>10871251</PMID>
  </reference>
  <reference>
    <citation>Pascual J, Colás R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep. 2001 Dec;5(6):529-36. Review.</citation>
    <PMID>11676887</PMID>
  </reference>
  <reference>
    <citation>Rozen TD. Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective). Headache. 2006 May;46(5):750-3.</citation>
    <PMID>16643577</PMID>
  </reference>
  <reference>
    <citation>Goadsby PJ. Migraine pathophysiology. Headache. 2005 Apr;45 Suppl 1:S14-24. Review.</citation>
    <PMID>15833086</PMID>
  </reference>
  <reference>
    <citation>Graff-Radford SB, Newman AC. The role of temporomandibular disorders and cervical dysfunction in tension-type headache. Curr Pain Headache Rep. 2002 Oct;6(5):387-91. Review.</citation>
    <PMID>12207852</PMID>
  </reference>
  <reference>
    <citation>Steele JG, Lamey PJ, Sharkey SW, Smith GM. Occlusal abnormalities, pericranial muscle and joint tenderness and tooth wear in a group of migraine patients. J Oral Rehabil. 1991 Sep;18(5):453-8.</citation>
    <PMID>1800695</PMID>
  </reference>
  <reference>
    <citation>Lamey PJ, Barclay SC. Clinical effectiveness of occlusal splint therapy in patients with classical migraine. Scott Med J. 1987 Feb;32(1):11-2.</citation>
    <PMID>3563468</PMID>
  </reference>
  <reference>
    <citation>Clark GT, Sakai S, Merrill R, Flack VF, McArthur D, McCreary C. Waking and sleeping temporalis EMG levels in tension-type headache patients. J Orofac Pain. 1997 Fall;11(4):298-306.</citation>
    <PMID>9656905</PMID>
  </reference>
  <reference>
    <citation>Graff-Radford SB. Oromandibular disorders and headache. A critical appraisal. Neurol Clin. 1990 Nov;8(4):929-45. Review.</citation>
    <PMID>2259320</PMID>
  </reference>
  <reference>
    <citation>Yap AU, Chua AP. Sleep bruxism: Current knowledge and contemporary management. J Conserv Dent. 2016 Sep-Oct;19(5):383-9. doi: 10.4103/0972-0707.190007. Review.</citation>
    <PMID>27656052</PMID>
  </reference>
  <reference>
    <citation>Burnett CA, Fartash L, Murray B, Lamey PJ. Masseter and temporalis muscle EMG levels and bite force in migraineurs. Headache. 2000 Nov-Dec;40(10):813-7.</citation>
    <PMID>11135025</PMID>
  </reference>
  <reference>
    <citation>Chandu A, Suvinen TI, Reade PC, Borromeo GL. The effect of an interocclusal appliance on bite force and masseter electromyography in asymptomatic subjects and patients with temporomandibular pain and dysfunction. J Oral Rehabil. 2004 Jun;31(6):530-7.</citation>
    <PMID>15189309</PMID>
  </reference>
  <reference>
    <citation>Nishigawa K, Bando E, Nakano M. Quantitative study of bite force during sleep associated bruxism. J Oral Rehabil. 2001 May;28(5):485-91.</citation>
    <PMID>11380790</PMID>
  </reference>
  <results_reference>
    <citation>Castillo J, Muñoz P, Guitera V, Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999 Mar;39(3):190-6.</citation>
    <PMID>15613213</PMID>
  </results_reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>April 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2021</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>single blinded study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

